Prospective Multicenter Study on Clinical Application of Sonazoid in Liver Tumor

NCT04563897 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 1300

Last updated 2020-09-25

No results posted yet for this study

Summary

Sonazoid as a new generation of ultrasound contrast agent.This study based on the features of Sonazoid specific angiography and his mechanical index, the role of Sonazoidin in the differential diagnosis of benign and malignant focal liver lesions in different liver background was explored

Conditions

  • Ultrasound

Sponsors & Collaborators

  • Chinese PLA General Hospital

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-10-01
Primary Completion
2021-05-01
Completion
2021-08-01

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04563897 on ClinicalTrials.gov